Vogler, SabineZimmermann, NinaBabar, Zaheer-Ud-DinBusse, ReinhardEspin-Balbino, JaimeMantel-Teeuwisse, Aukje KPanteli, DimitraSuleman, FatimaWirtz, Veronika J2023-02-092023-02-092021-01-25Vogler S, Zimmermann N, Babar ZU, Busse R, Espin J, Mantel-Teeuwisse AK, et al. Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference. J Pharm Policy Pract. 2021 Jan 25;14(1):18.2052-3211http://hdl.handle.net/10668/17038The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Access to medicinesAffordabilityCollaborationDebateMedicine pricesPolicy optionsPricing policiesReimbursementHealth Services AccessibilityMedicine pricesReimbursement MechanismsEconomics, Pharmaceuticalresearch article33494798open accessAccesibilidad a los Servicios de SaludPrecio de MedicamentoMecanismo de ReembolsoEconomía Farmacéutica10.1186/s40545-021-00300-3PMC7829652https://doi.org/10.1186/s40545-021-00300-3https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829652/pdf